Category: clinical study retractions

Upon request, NEJM added note to help Texas distance itself from Planned Parenthood article

Screen Shot 2016-03-30 at 1.41.39 PM

The New England Journal of Medicine added a disclaimer to a recent article about the effects of funding cuts to Planned Parenthood, after a request from the Texas Health and Human Services Commission, saying it wanted to distance itself from the paper.

Since the paper was published in February, one author has stepped down from his position at HHSC after facing disciplinary action.

The article suggested that birth rates among a group of lower-income women increased after the state cut down on support for Planned Parenthood. It drew a significant amount of media attention — and concern from the HHSC, which asked the journal to add a disclaimer to the article soon after publication. The journal complied, but embargoed the announcement of the change until 5 p.m. eastern time today.

Here’s the disclaimer that NEJM added to the article:

Continue reading Upon request, NEJM added note to help Texas distance itself from Planned Parenthood article

Study on teens with scoliosis failed to seek ethics approval, erratum notes

Screen Shot 2016-03-07 at 3.29.57 PMAfter researchers failed to seek ethics approval for a study on teens with scoliosis, a journal has issued an erratum to the paper.

The journal is not retracting the paper outright, it says, because the study was non-invasive and likely would have received ethics approval.

During the study, teenagers with and without progressive scoliosis underwent a physical examination and participated in an interview along with a parent, with the goal of trying to uncover risk factors for the condition.

Here’s the full erratum from Scoliosis and Spinal Disorders for “Physical activities of Patients with adolescent idiopathic scoliosis (AIS): preliminary longitudinal case–control study historical evaluation of possible risk factors:”

Continue reading Study on teens with scoliosis failed to seek ethics approval, erratum notes

Son sees dead father in case report, requests retraction

ijscrAuthors have retracted a case report describing a surgery to remove gallstones in a patient with Crohn’s disease after learning they’d mixed up two cases, and instead reported on a patient who had died 21 days after the procedure.

We were alerted to this story by La Repubblica, and contacted by the son of the patient (who asked not to be named, for privacy reasons). He told us he found the study and asked the journal to retract it:

…I can say that it was absolutely devastating to realise that the pictures I was looking at were from the surgery that led to the death of my father. It is something that gives me a lot of sorrow thinking that the man in that picture with the open belly was him, when he was fighting for his life. I asked the rest of my family not to see them to avoid them the same shock.

Even before the retraction appeared, we received confirmation it was coming from Giuseppe Paolisso, the Principal of the School of Medicine at the Second University of Naples, where the authors are based: Continue reading Son sees dead father in case report, requests retraction

Ethics committee asks journal to retract paper about controversial growth-stunting treatment

cdso20.v030.i07.cover

A journal has retracted a paper on a controversial course of treatment used to stunt the growth of disabled children, at the request of the human research ethics committee at the University of Waikato in New Zealand.

The paper described the so-called Ashley Treatment — explored last week in the New York Times — in which disabled children receive hormones and procedures to keep them small and diminish the effects of puberty, making it easier for them to be cared for. The retracted paper analyzed the use of the treatment in a girl named Charley who was born in New Zealand with a brain injury, whose case has attracted the attention of The Washington Post and People magazine, among other outlets.

The paper analyzed Charley’s case, and did not involve any clinical subjects. But the retraction note suggests that the ethics of publishing this paper weren’t fully worked out:

Continue reading Ethics committee asks journal to retract paper about controversial growth-stunting treatment

How does an abstract get published without any of the authors knowing?

369Thrombosis Research has removed an abstract after all seven authors authors listed did not know that it had been submitted for publication.

We’ve seen many instances of some authors not being in on a submission, but a case in which all of the authors are in the dark? That’s new to us.

A spokesperson for Elsevier, the journal’s publisher, told us that the organizers of a conference submitted it to the journal as part of a supplement for a meeting, unbeknownst to the authors.

Here’s the odd “removal notice” for “The Characterisation of the Age-Specific Differences in Platelet Physiology and Function:”

Continue reading How does an abstract get published without any of the authors knowing?

Neuroscience journal retracts paper for lack of “scientific soundness”

Screen Shot 2016-03-03 at 9.21.12 AMAn unusual article that considered the concept of change from a systems perspective — including change in medicine, economics, and decision-making, for instance — has, well, changed from “published” to “retracted.”

After commenters on PubPeer called the 2014 paper “gibberish” and even suggested it might be computer-generated, Frontiers in Computational Neuroscience retracted it, noting it “does not meet the standards of editorial and scientific soundness” for the journal, according to the retraction notice. The paper’s editor and author maintain there was nothing wrong with the science in the paper.

Here’s the full note for “Sensing risk, fearing uncertainty: systems science approach to change:” Continue reading Neuroscience journal retracts paper for lack of “scientific soundness”

NFL and NYT collide: Did studies on concussion rates leave out necessary data?

National Football LeagueThe National Football League failed to include data from diagnosed concussions in peer-reviewed studies, making the sport look safer than it is, allege the results of an investigation published yesterday in the New York Times. Now, the paper and the NFL are arguing over whether the studies were supposed to include every instance of head injury.

Early studies on concussion rates published in the journal Neurosurgery left out at least 100 instances of of concussions, the Times reported. The Times and the NFL disagree on the implications of studies based on an incomplete data set: Sources told the Times that it’s bad science, while the NFL explains that the studies were “necessarily preliminary.”

Yesterday afternoon, the sports league published a statement saying that the Times story “is contradicted by clear facts” and “sensationalized.” The statement argued that:  Continue reading NFL and NYT collide: Did studies on concussion rates leave out necessary data?

Family squabble over safety of eye therapy forces journal to pull paper

Screen Shot 2016-03-11 at 5.41.35 PM

A father and son are fighting over whether a laser therapy they describe as co-authors of a 2015 paper could be harmful to patients, prompting the journal to retract the article.

The small study suggested that the therapy could safely treat patients with glaucoma. But Tomislav Ivandic — the father — alleges that errors in how the study was reported could lead to harmful doses of laser light for patients receiving the therapy. His son and co-author, Boris Ivandic, maintains that the article is accurate.

To err on the side of patient safety, Photomedicine and Laser Surgery retracted “Effects of Photobiomodulation Therapy on Patients with Primary Open Angle Glaucoma: A Pilot Study.”

The retraction note explains the dispute:

Continue reading Family squabble over safety of eye therapy forces journal to pull paper

Lawsuit couldn’t stop four retractions for diabetes researcher

Mario Saad
Mario Saad

Four expressions of concern in the journal Diabetes have turned into retractions for Mario Saad, a move which he had tried to stop with a lawsuit.

Last August, a judge dismissed Saad’s suit against the American Diabetes Association, which publishes Diabetes, concluding that the expressions of concerns on the papers were not defamation, but part of an “ongoing scientific discourse.” Now, after an investigation at the University of Campinas in Brazil, where Saad is based, and an assessment from an ADA ethics panel (which overturned some of Unicamp’s recommendations), the journal has added to that discourse by turning the EOCs into retractions — and flagging two more of Saad’s papers with EOCs.

Together, the retracted papers have been cited more than 600 times.

As the retraction notes explain, Continue reading Lawsuit couldn’t stop four retractions for diabetes researcher

Biologist’s research under investigation in Sweden after being questioned on PubPeer

Holgersson
Suchitra Sumitran-Holgersson

The University of Gothenburg in Sweden is investigating several papers co-authored by biologist Suchitra Sumitran-Holgersson after they were challenged on PubPeer.

Sumitran-Holgersson already has one retraction under her belt — of a 2005 Blood paper, after another investigation concluded the results “cannot be considered reliable.” Sumitran-Holgersson and her husband, co-author Jan Holgersson, did not sign the retraction notice. Both were based at the Karolinska Institutet (KI) at the time, but have since moved to the University of Gothenburg.

Now, the University of Gothenburg has launched its own investigation of the papers questioned on PubPeer, according to Continue reading Biologist’s research under investigation in Sweden after being questioned on PubPeer